Risk management and internal control

The Board ensures that good internal control and appropriate systems for risk management are introduced in order to help eliminate unnecessary risks to which the company is exposed to through its activities. Typical risks the company is exposed to include operational risk, foreign currency risk, financial risk and risks associated with the markets the company is involved in with respect to the laws and regulations in the individual countries with which the company must comply.

A new auditor was elected in the Ordinary Annual General Meeting in 2014, and there will be carried out annual meetings in order to evaluate the company’s financial status, risk exposures and internal control.

Furthermore, the Board contributes ensuring the quality of internal and external reporting, help to ensure that the company is properly run from a business perspective with respect to the adopted ethical norms and standards, and that the company keeps within the applicable laws, rules and regulations. The company has not implemented ethical guidelines.

Contact Us

NattoPharma ASA
(head office)
Lilleakerveien 2B
0283 Oslo, Norway
Tel: (+47) 40 00 90 08

NattoPharma USA, Inc.
(North American Subsidiary)
328 Amboy Avenue, Ste. D
Metuchen, NJ 08840, USA
Tel: (+1) 609-454-2992

NattoPharma contact information:
Main office: Lilleakerveien 2B, 0283 Oslo,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+47) 40 00 90 08
Tel: (+1) 609-454-2992
Created by:
Nutricon logo.
Search term: